CHARLES SCHWAB INVESTMENT MANAGEMENT INC
Position in JANX — Janux Therapeutics, Inc.
CIK 884546
SAN FRANCISCO, CA
Position in JANX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,925,159
-$463,823 QoQ
Shares Held
354,328
-9.3% QoQ
Ownership
0.581%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2021
19 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in JANX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026CHARLES SCHWAB INVESTMENT MANAGEMENT INC holds $6,182,986,350 across 288 Biotechnology names. JANX ranks #132 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
1,920,871 | $857,745,736 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
804,508 | $621,595,061 | |
| 3 | MRNA |
Moderna, Inc.
|
4,734,356 | $240,505,284 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
673,356 | $222,793,299 | |
| 5 | INSM |
INSMED Inc
|
1,069,390 | $174,866,652 | |
| 6 | RVMD |
Revolution Medicines, Inc.
|
1,735,476 | $168,775,041 | |
| 7 | INCY |
Incyte Corp
|
1,729,102 | $162,743,080 | |
| 8 | BBIO |
BridgeBio Pharma, Inc.
|
1,976,094 | $146,744,740 |
All Filings in JANX
Export CSV
19 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,925,159 | 354,328 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $5,388,982 | 390,506 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $8,665,055 | 354,544 | Shares | Sole | 2025-11-10 | |
| 2025-06-30 | $6,915,608 | 299,377 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $7,388,361 | 273,643 | Shares | Sole | 2025-09-15 | |
| 2024-12-31 | $14,623,647 | 273,135 | Shares | Sole | 2025-02-06 | |
| 2024-09-30 | $10,639,297 | 234,191 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $3,247,145 | 77,516 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,854,563 | 49,258 | Shares | Sole | 2024-05-09 | |
| 2023-12-31 | $495,092 | 46,141 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $491,400 | 48,750 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $547,456 | 46,121 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $549,243 | 45,392 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $628,077 | 47,690 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $630,463 | 46,563 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $519,047 | 42,510 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $636,696 | 44,400 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $669,754 | 33,946 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $704,618 | 32,576 | Shares | Sole | 2021-11-16 | |
| No filing history on record for this holder in this stock. | ||||||